Literature DB >> 22526032

Diagnostic value of FDG-PET/CT for lymph node metastasis of colorectal cancer.

Jae Young Kwak1, Jae Seung Kim, Hye Jin Kim, Hyun Kwon Ha, Chang Sik Yu, Jin Cheon Kim.   

Abstract

BACKGROUND: Lymph node metastasis is an important prognostic factor in patients with colorectal cancer. We assessed the ability of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) to diagnose lymph node metastases in colorectal cancer patients.
METHODS: We retrospectively analyzed the records of 473 patients who underwent preoperative FDG-PET/CT, followed by curative surgery for colorectal cancer. Lymph node metastases were assessed as proximal or distal, depending on their anatomical location. We analyzed the sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy of FDG-PET/CT and CT for detecting lymph node metastases.
RESULTS: In detecting proximal lymph nodes, FDG-PET/CT had a sensitivity of 66 %, a specificity of 60 %, a PPV of 63 %, an NPV of 62 %, and an accuracy of 63 %; whereas CT had a sensitivity of 87 %, a specificity of 29 %, a PPV of 57 %, an NPV of 68 %, and an accuracy of 59 % (P = 0.245). FDG-PET/CT and CT also showed similar accuracy in detecting distal lymph nodes (87 vs. 88 %, P = 0.620).
CONCLUSION: Preoperative FDG-PET/CT and CT have comparable accuracy in detecting lymph node metastases of colorectal cancer.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22526032     DOI: 10.1007/s00268-012-1575-3

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  41 in total

1.  GLUT1 expression in tissue and (18)F-FDG uptake.

Authors:  Norbert Avril
Journal:  J Nucl Med       Date:  2004-06       Impact factor: 10.057

2.  Efficacy of PET/CT in the accurate evaluation of primary colorectal carcinoma.

Authors:  I J Park; H C Kim; C S Yu; M H Ryu; H M Chang; J H Kim; J S Ryu; J S Yeo; J C Kim
Journal:  Eur J Surg Oncol       Date:  2006-07-13       Impact factor: 4.424

3.  Indication and benefit of pelvic sidewall dissection for rectal cancer.

Authors:  Kenichi Sugihara; Hirotoshi Kobayashi; Tomoyuki Kato; Takeo Mori; Hidetaka Mochizuki; Shingo Kameoka; Kazuo Shirouzu; Tetsuichiro Muto
Journal:  Dis Colon Rectum       Date:  2006-11       Impact factor: 4.585

4.  Number of nodes examined and staging accuracy in colorectal carcinoma.

Authors:  J H Wong; R Severino; M B Honnebier; P Tom; T S Namiki
Journal:  J Clin Oncol       Date:  1999-09       Impact factor: 44.544

5.  Prognostic significance of distribution of lymph node metastasis in advanced mid or low rectal cancer.

Authors:  Jin Soo Kim; Dae Kyung Sohn; Ji Won Park; Dae Yong Kim; Hee Jin Chang; Hyo Seong Choi; Jae Hwan Oh
Journal:  J Surg Oncol       Date:  2011-05-02       Impact factor: 3.454

6.  Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: correlation with histopathologic and CT findings.

Authors:  H Abdel-Nabi; R J Doerr; D M Lamonica; V R Cronin; P J Galantowicz; G M Carbone; M B Spaulding
Journal:  Radiology       Date:  1998-03       Impact factor: 11.105

7.  Detection of lymph node metastases in colorectal carcinoma.

Authors:  S T O'Dwyer; N Y Haboubi; J S Johnson; R Gardy
Journal:  Colorectal Dis       Date:  2001-09       Impact factor: 3.788

8.  Improvement of the diagnostic accuracy of lymph node metastases of colorectal cancer in 18F-FDG-PET/CT by optimizing the iteration number for the image reconstruction.

Authors:  Kazumasa Inoue; Takashi Sato; Hideaki Kitamura; Masaaki Ito; Yoshiyuki Tsunoda; Akira Hirayama; Hideo Kurosawa; Takashi Tanaka; Masahiro Fukushi; Noriyuki Moriyama; Hirofumi Fujii
Journal:  Ann Nucl Med       Date:  2008-08-01       Impact factor: 2.668

9.  Classification of colorectal carcinomas with regional lymphatic metastases.

Authors:  P Hermanek; A Altendorf
Journal:  Pathol Res Pract       Date:  1981-12       Impact factor: 3.250

10.  Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography.

Authors:  Didier Lardinois; Walter Weder; Thomas F Hany; Ehab M Kamel; Stephan Korom; Burkhardt Seifert; Gustav K von Schulthess; Hans C Steinert
Journal:  N Engl J Med       Date:  2003-06-19       Impact factor: 91.245

View more
  16 in total

1.  Accuracy of computed tomography in nodal staging of colon cancer patients.

Authors:  Audrey H Choi; Rebecca A Nelson; Hans F Schoellhammer; Won Cho; Michelle Ko; Amanda Arrington; Christopher R Oxner; Marwan Fakih; Jimmie Wong; Stephen M Sentovich; Julio Garcia-Aguilar; Joseph Kim
Journal:  World J Gastrointest Surg       Date:  2015-07-27

2.  Diagnostic value of FDG-PET/CT for lateral pelvic lymph node metastasis in rectal cancer treated with preoperative chemoradiotherapy.

Authors:  S Ishihara; K Kawai; T Tanaka; T Kiyomatsu; K Hata; H Nozawa; T Morikawa; T Watanabe
Journal:  Tech Coloproctol       Date:  2018-04-06       Impact factor: 3.781

3.  Reliability of (18)f-fluorodeoxyglucose positron emission tomography/computed tomography in the nodal staging of colorectal cancer patients.

Authors:  Hee Jung Yi; Kyung Sook Hong; Nara Moon; Soon Sup Chung; Ryung-Ah Lee; Kwang Ho Kim
Journal:  Ann Coloproctol       Date:  2014-12-31

4.  A scoring system to predict inferior mesenteric artery lymph node metastasis and prognostic value of its involvement in rectal cancer.

Authors:  Xiao-Jie Wang; Pan Chi; Hui-Ming Lin; Xing-Rong Lu; Ying Huang; Zong-Bin Xu; Sheng-Hui Huang; Yan-Wu Sun
Journal:  Int J Colorectal Dis       Date:  2013-12-15       Impact factor: 2.571

5.  Transabdominal Ultrasonography for Preoperative Diagnosis of Lymph Node Metastasis in Colon Cancer: A Retrospective Cohort Study.

Authors:  Ken Imaizumi; Shigenori Homma; Mutsumi Nishida; Takeshi Soyama; Ryosuke Shimura; Yusuke Kudo; Satomi Omotehara; Isao Yokota; Ryo Takagi; Hiroki Matsui; Yoichi Miyaoka; Nobuki Ichikawa; Tadashi Yoshida; Norihiko Takahashi; Akinobu Taketomi
Journal:  Cancer Diagn Progn       Date:  2022-03-03

6.  Assessment of metastatic colorectal cancer with hybrid imaging: comparison of reading performance using different combinations of anatomical and functional imaging techniques in PET/MRI and PET/CT in a short case series.

Authors:  C Brendle; N F Schwenzer; H Rempp; H Schmidt; C Pfannenberg; C la Fougère; K Nikolaou; C Schraml
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-07-31       Impact factor: 9.236

7.  Clinical evaluation of (18)F-fludeoxyglucose positron emission tomography/CT using point spread function reconstruction for nodal staging of colorectal cancer.

Authors:  Kazuya Kawashima; Kenichi Kato; Makiko Tomabechi; Mikaru Matsuo; Koki Otsuka; Kazuyuki Ishida; Ryuji Nakamura; Shigeru Ehara
Journal:  Br J Radiol       Date:  2016-05-05       Impact factor: 3.039

8.  Pre-operative TNM staging of primary colorectal cancer by (18)F-FDG PET-CT or PET: a meta-analysis including 2283 patients.

Authors:  Yanwei Ye; Tao Liu; Lisha Lu; Guojun Wang; Min Wang; Jingjing Li; Chao Han; Jianguo Wen
Journal:  Int J Clin Exp Med       Date:  2015-11-15

9.  Preoperative Computerized Tomographic Assessment of Regional Lymph Node and Extramural Vascular Invasion in Colonic Cancer.

Authors:  Andrew T W McAvoy; Krishnan Gokul; Apam Chiphang; Dmitri Y Artioukh
Journal:  Eurasian J Med       Date:  2018-06-01

Review 10.  Value of PET imaging for radiation therapy.

Authors:  Constantin Lapa; Ursula Nestle; Nathalie L Albert; Christian Baues; Ambros Beer; Andreas Buck; Volker Budach; Rebecca Bütof; Stephanie E Combs; Thorsten Derlin; Matthias Eiber; Wolfgang P Fendler; Christian Furth; Cihan Gani; Eleni Gkika; Anca-L Grosu; Christoph Henkenberens; Harun Ilhan; Steffen Löck; Simone Marnitz-Schulze; Matthias Miederer; Michael Mix; Nils H Nicolay; Maximilian Niyazi; Christoph Pöttgen; Claus M Rödel; Imke Schatka; Sarah M Schwarzenboeck; Andrei S Todica; Wolfgang Weber; Simone Wegen; Thomas Wiegel; Constantinos Zamboglou; Daniel Zips; Klaus Zöphel; Sebastian Zschaeck; Daniela Thorwarth; Esther G C Troost
Journal:  Strahlenther Onkol       Date:  2021-07-14       Impact factor: 3.621

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.